USPTO Examiner MEDWAY SCOTT J - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18815556SOLUTION PREPARATION DEVICE AND NASAL IRRIGATORAugust 2024April 2025Allow701NoNo
18784148INFUSION SET AND INSERTER ASSEMBLY SYSTEMS AND METHODSJuly 2024May 2025Allow911YesNo
18757728Medicament Delivery Device and Actuation Mechanism for a Drug Delivery DeviceJune 2024April 2025Allow910YesNo
18679544FLOW DIRECTING MEDICINAL APPLICATORMay 2024July 2024Allow200NoNo
18525883NASAL CATHETER TO PREVENT NEGATIVE PRESSUREDecember 2023August 2024Allow920NoNo
18507948TWO BALLOON CATHETERS FOR ASPIRATION AND CONTROLLED DELIVERY OF CLOSURE AGENTSNovember 2023December 2024Allow1310NoNo
18381754PORTABLE SUCTION SYSTEMOctober 2023February 2025Allow1630NoNo
18483487INSULIN MANAGEMENTOctober 2023April 2024Allow720NoNo
18233703DEVICES, SYSTEMS AND METHODS FOR REMOVAL AND REPLACEMENT OF A CATHETER FOR AN IMPLANTED ACCESS PORTAugust 2023April 2025Allow2010NoNo
18364357SEGMENTAL VASCULAR ABLATIONAugust 2023February 2024Allow711NoNo
18209507DISPOSABLE NASAL AND EYE WASH DISPENSERJune 2023November 2024Allow1720NoNo
18315740EXPANDABLE INTRODUCER SHEATH TO PRESERVE GUIDEWIRE ACCESSMay 2023June 2025Allow2620NoNo
18140280THROMBUS ASPIRATION SYSTEM AND METHODS FOR CONTROLLING BLOOD LOSSApril 2023November 2023Allow710NoNo
18187531Breast Shield with Suckling Motion One-Way ValveMarch 2023August 2023Allow510YesNo
18187565Tamper-Evident Enclosure for PICC LineMarch 2023December 2024Allow2010NoNo
18175448MEDICAL IMPLEMENT FOR PROVIDING SUCTION AND IRRIGATIONFebruary 2023March 2024Allow1220YesNo
18172147POSITIVE DISPLACEMENT SHUTTLE PUMP HEART AND VADFebruary 2023May 2025Abandon2710NoNo
18050591Insulin ManagementOctober 2022June 2023Allow810YesNo
17949930MULTIPLE-USE INTRAVENOUS CATHETER ASSEMBLY SEPTUM AND SEPTUM ACTUATORSeptember 2022September 2024Allow2410YesNo
17944209IMPLANTABLE INFUSION DEVICES AND METHODSSeptember 2022July 2024Allow2210NoNo
17941811NEEDLELESS CONNECTOR AND ACCESS PORT DISINFECTION CLEANER AND ANTIMICROBIAL PROTECTION CAPSeptember 2022January 2025Allow2940YesNo
17929141INTRAVITREAL INJECTORSeptember 2022February 2025Abandon3010NoNo
17895360FLOW DIRECTING MEDICINAL APPLICATORAugust 2022October 2023Abandon1420YesNo
17894842FLUID SOURCE MANAGEMENT SYSTEMAugust 2022March 2023Allow710NoNo
17904455BREAST SHIELDAugust 2022August 2023Allow1230YesNo
17819481Breast PumpAugust 2022March 2024Allow1940YesNo
17876302METHODS AND SYSTEMS FOR IMPLANTABLE MEDICAL DEVICES AND VASCULARIZATION MEMBRANESJuly 2022December 2023Abandon1720NoNo
17871242ARTHROSCOPIC DEVICES AND METHODSJuly 2022March 2024Allow1910NoNo
17865015PRIMING APPARATUS AND METHODJuly 2022January 2024Allow1810NoNo
17758555FLUID TRANSFER DEVICEJuly 2022April 2024Allow2120NoNo
17744824PATIENT FLUID LINE ACCESS VALVE ANTIMICROBIAL CAP/CLEANERMay 2022June 2025Abandon3730YesNo
17741049BLOOD CONTROL IV CATHETER WITH STATIONARY SEPTUM ACTIVATORMay 2022August 2024Allow2810YesNo
17726788THROMBUS ASPIRATION SYSTEM AND METHODS FOR CONTROLLING BLOOD LOSSApril 2022May 2023Allow1220YesNo
17726787THROMBUS ASPIRATION SYSTEM AND METHODS FOR CONTROLLING BLOOD LOSSApril 2022April 2023Allow1220YesNo
17726791THROMBUS ASPIRATION SYSTEM AND METHODS FOR CONTROLLING BLOOD LOSSApril 2022April 2023Allow1220YesNo
17659652Insulin ManagementApril 2022June 2022Allow200NoNo
17718594CATHETER ADAPTER PORT VALVEApril 2022February 2024Allow2210NoNo
17710241Safety Device for a Medicament ContainerMarch 2022October 2024Allow3020NoNo
17694852COMPONENTS WITH HIGH API LOADINGMarch 2022March 2024Allow2410NoNo
17575538SYSTEM AND METHOD FOR MANIPULATING AN ELONGATE MEDICAL DEVICEJanuary 2022December 2024Abandon3620NoNo
17549373SUBCUTANEOUS INSERTION SYSTEMS; DEVICES AND RELATED METHODSDecember 2021January 2024Allow2510NoNo
17616386INGESTIBLE DEVICE WITH DELIVERY MEMBER DETACHMENTDecember 2021February 2025Abandon3800NoNo
17508668METHOD AND SYSTEM FOR OPERATING A PLUNGEROctober 2021August 2024Allow3410NoNo
17496016Subcutaneous Anchor Device for Securing a CatheterOctober 2021August 2023Allow2210NoNo
17493692CONCURRENT INFUSION WITH COMMON LINE AUTO FLUSHOctober 2021September 2024Allow3620NoNo
17598112A DEVICE FOR THE TREATMENT OF ANAL FISTULA-IN-ANO AND COMPLEX FISTULA-IN-ANOSeptember 2021June 2025Allow4430YesNo
17482090ARTHROSCOPIC DEVICES AND METHODSSeptember 2021March 2024Allow2940NoNo
17473838BREAST PUMPSeptember 2021June 2022Allow920YesNo
17462070THERAPEUTIC SWABS FOR TREATING UPPER RESPIRATORY INFECTIONSAugust 2021May 2023Allow2160YesNo
17404418DEVICE AND METHODS FOR TREATING PARANASAL SINUS CONDITIONSAugust 2021October 2023Abandon2610NoNo
17404795PERITONEAL DIALYSIS SYSTEM AND CONTINUOUS GLUCOSE MONITORINGAugust 2021May 2025Abandon4421NoNo
17379801IRRIGATED ABLATION ELECTRODE HAVING SMOOTH EDGES TO MINIMIZE TISSUE CHARJuly 2021October 2023Allow2720NoNo
17374226FLUID CONDUIT ASSEMBLY WITH GAS TRAPPING FILTER IN THE FLUID FLOW PATHJuly 2021June 2023Allow2310NoNo
17363554BALANCED FLOW DIALYSIS MACHINEJune 2021October 2023Allow2810NoNo
17345760CATHETER HOLE HAVING A FLOW BREAKING FEATUREJune 2021April 2023Allow2310YesNo
17324529SOCKETED PORTAL ANCHORS AND METHODS OF USING SAMEMay 2021June 2024Allow3720NoNo
17323835NEEDLELESS CONNECTOR WITH SUPPORT MEMBERMay 2021April 2023Allow2310NoNo
17309298BLOOD FLOW ASSISTING PORTABLE ARM SUPPORTMay 2021April 2023Abandon2340YesNo
17318799PINCH CLAMP DEVICEMay 2021April 2023Allow2310NoNo
17201810Guidewire FixationMarch 2021February 2025Allow4710NoNo
17194220NASAL COMPRESSION DEVICEMarch 2021October 2024Abandon4430NoNo
17182398BREAST PUMP HOUSING AND FLANGE ASSEMBLYFebruary 2021September 2024Allow4320YesNo
17172972Injection Site Information CapFebruary 2021March 2023Allow2510NoNo
17248640DEVICES, SYSTEMS AND METHODS FOR REMOVAL AND REPLACEMENT OF A CATHETER FOR AN IMPLANTED ACCESS PORTFebruary 2021March 2023Allow2610YesNo
17148073DYNAMIC CURVE ACCESS TOOL FOR COMPLEX ARCH ANATOMIES AND RADIAL ACCESSJanuary 2021March 2023Allow2610NoNo
17147112WEARABLE DRUG DELIVERY DEVICE FOR DISEASE MANAGEMENT AND SYSTEM THEREFOR WITH ARTIFICIAL INTELLIGENCEJanuary 2021February 2024Allow3710NoNo
17259640ROTARY PLUNGER PUMP SUBSYSTEMSJanuary 2021February 2022Allow1310NoNo
17137614BALLOON CATHETERDecember 2020May 2024Allow4020NoNo
17130544REDUCING IRRIGATION/ASPIRATION VALVE RESPONSE TIME IN A PHACOEMULSIFICATION SYSTEMDecember 2020December 2024Allow4850NoNo
17125946SPRING FOR AN INJECTION DEVICEDecember 2020November 2024Abandon4720NoNo
17124479SYSTEMS AND METHODS FOR PROVIDING A PULSELESS PERISTALTIC PUMPDecember 2020June 2025Allow5460YesNo
17124486SYSTEM LEVEL FLUIDICS AND CONTROLSDecember 2020February 2025Allow5060NoNo
16973182Pharmaceutical Product Preparation Device and MethodDecember 2020April 2025Abandon5201NoNo
17114359CONCURRENT INFUSION WITH COMMON LINE AUTO FLUSHDecember 2020June 2021Allow610YesNo
16972585Improvements in, or relating to, applicatorsDecember 2020July 2024Allow4420NoNo
17105039SAFETY MECHANISM FOR AN AUTOINJECTORNovember 2020June 2023Allow3110NoNo
16951289EXPANDABLE INTRODUCER SHEATH TO PRESERVE GUIDEWIRE ACCESSNovember 2020February 2023Allow2710YesNo
17091662Fluid Management Systems and MethodsNovember 2020December 2024Allow5011YesNo
17091027INSUFFLATION SYSTEMNovember 2020March 2023Allow2910NoNo
17083642IRRIGATION SLEEVE FOR OPHTHALMIC PROCEDURESOctober 2020August 2023Allow3420NoNo
17067364SYSTEMS AND METHODS FOR DELIVERY OF PERITONEAL DIALYSIS (PD) SOLUTIONS WITH INTEGRATED INTER-CHAMBER DIFFUSEROctober 2020July 2023Allow3310YesNo
17064370DEVICES AND METHODS FOR CONTINUOUS DRUG DELIVERY VIA THE MOUTHOctober 2020December 2023Abandon3820NoNo
17036605MANUAL BREAST PUMPSeptember 2020July 2021Allow910NoNo
17019704INJECTORSeptember 2020May 2025Allow5650NoNo
17011607Medicament Delivery Device and Actuation Mechanism for a Drug Delivery DeviceSeptember 2020October 2023Allow3830YesNo
17002313DEVICE AND METHOD FOR SETTING THERAPEUTIC PARAMETERS FOR AN INFUSION DEVICEAugust 2020September 2023Abandon3720YesNo
16997749ENDOSCOPY TOOLS AND METHODS OF USEAugust 2020November 2021Allow1530YesNo
16991747DressingAugust 2020September 2024Allow4920NoYes
16939314DEVICE FOR PREVENTING ACCIDENTAL SEPARATION OF A DRIP TUBE FROM AN IV MEDICATION BAG OR BOTTLEJuly 2020April 2023Abandon3210NoNo
16933850SELF-POWERED SYRINGE DRIVERSJuly 2020January 2024Allow4221YesNo
16922825CATHETER INCLUDING VARIABLE DENSITY STRUCTURAL SUPPORT MEMBERJuly 2020January 2024Allow4260YesNo
16905960AUTOINJECTOR WITH SHOCK REDUCING ELEMENTSJune 2020March 2024Allow4440YesNo
16946257INLINE PUMP WITH REAR ATTACHABLE SYRINGEJune 2020August 2022Allow2610NoNo
16896640Methods and Compositions for Treating a Renal Disease Condition in a SubjectJune 2020May 2025Abandon5980NoNo
16892047Medicament Delivery Device and Actuation Mechanism for a Drug Delivery DeviceJune 2020April 2025Allow5960YesNo
16876992Patch-Sized Fluid Delivery Systems and MethodsMay 2020May 2023Abandon3611NoNo
15930974EXPANDABLE BALLOON SHEATHSMay 2020February 2025Allow5751YesNo
16762386METHOD AND SYSTEM FOR ACTIVE IRRIGATION OF AN OPHTHALMIC SURGICAL SITEMay 2020April 2023Allow3520NoNo
16867361POSITIVE DISPLACEMENT SHUTTLE PUMP HEART AND VADMay 2020November 2022Allow3010NoNo
16864773Using Alternating Electric Fields to Increase Cell Membrane PermeabilityMay 2020May 2021Allow1320YesYes

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner MEDWAY, SCOTT J.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
13
Examiner Affirmed
7
(53.8%)
Examiner Reversed
6
(46.2%)
Reversal Percentile
68.0%
Higher than average

What This Means

With a 46.2% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
33
Allowed After Appeal Filing
11
(33.3%)
Not Allowed After Appeal Filing
22
(66.7%)
Filing Benefit Percentile
52.7%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner MEDWAY, SCOTT J - Prosecution Strategy Guide

Executive Summary

Examiner MEDWAY, SCOTT J works in Art Unit 3783 and has examined 341 patent applications in our dataset. With an allowance rate of 73.3%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 41 months.

Allowance Patterns

Examiner MEDWAY, SCOTT J's allowance rate of 73.3% places them in the 29% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by MEDWAY, SCOTT J receive 3.41 office actions before reaching final disposition. This places the examiner in the 99% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by MEDWAY, SCOTT J is 41 months. This places the examiner in the 7% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +20.8% benefit to allowance rate for applications examined by MEDWAY, SCOTT J. This interview benefit is in the 69% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 15.8% of applications are subsequently allowed. This success rate is in the 7% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 27.3% of cases where such amendments are filed. This entry rate is in the 30% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 157.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 90% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 63.9% of appeals filed. This is in the 38% percentile among all examiners. Of these withdrawals, 56.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 32.5% are granted (fully or in part). This grant rate is in the 25% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.6% of allowed cases (in the 61% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.